CUTANEOUS SQUAMOUS CELL CARCINOMA
Clinical trials for CUTANEOUS SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for CUTANEOUS SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug IDP-001 takes on advanced cancers in early trial
Disease control Not yet recruitingThis study tests a new drug called IDP-001 in people with advanced or spreading solid tumors, including certain lung, head and neck, and other cancers. The main goals are to check the drug's safety, find the right dose, and see if it can shrink tumors. About 132 adults who have t…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: InduPro, Inc. • Aim: Disease control
Last updated May 26, 2026 06:23 UTC
-
New hope for skin cancer patients with complex medical histories
Disease control Not yet recruitingThis study tests a drug called cosibelimab in 80 people with advanced skin cancer who also have a kidney transplant or a blood cancer. The goal is to see if the drug is safe and shrinks tumors. Participants receive the drug by IV and are monitored for side effects and response.
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE4 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 26, 2026 06:17 UTC